[Clinical experience with Lindigoa-depot-dragées in vascular diseases].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004928:Escin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009756:Nylidrin / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use; D014648:Varicose Veins / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006896:Hydroxyethylrutoside; D004928:Escin; D009756:Nylidrin; D011736:Pyridoxine; D013831:Thiamine
Klinische Erfahrungen mit Lindigoa-Depot-Dragées bei Venener-krankungen